Dehydroepiandrosterone negatively regulates the p38 mitogen-activated protein kinase pathway by a novel mitogen-activated protein kinase phosphatase

Biochimica et Biophysica Acta - Gene Structure and Expression

Volumn 1728, Issue 1-2, 2005, Pages 84-94

  Ashida, Kenji ^a   Goto, Kiminobu ^a   Zhao, Yue ^a   Okabe, Taijiro ^a   Yanase, Toshihiko ^a   Takayanagi, Ryoichi ^a   Nomura, Masatoshi ^a   Nawata, Hajime ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Dehydroepiandrosterone; Dual specificity protein phosphatase; Mitogen activated protein kinase; Mitogen activated protein kinase phosphatase; p38 mitogen activated protein kinase; Protein tyrosine phosphatase

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; PRASTERONE SULFATE; PROTEIN TYROSINE PHOSPHATASE;

AMINO ACID SEQUENCE; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME REGULATION; ENZYME SPECIFICITY; GENE EXPRESSION; HORMONAL REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; TISSUE SPECIFICITY;

EID: 15744393429     PISSN: 01674781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbaexp.2005.01.016     Document Type: Article

References (41)

1. R.J. Davis The mitogen-activated protein kinase signal transduction pathway J. Biol. Chem. 268 1993 14553 14556
2. Z. Galcheva-Gargova, B. Derijard, I.H. Wu, and R.J. Davis An osmosensing signal transduction pathway in mammalian cells Science 265 1994 806 808
3. J.M. Kyriakis, P. Banerjee, E. Nikolakaki, T. Dai, E.A. Rubie, M.F. Ahmad, J. Avruch, and J.R. Woodgett The stress-activated protein kinase subfamily of c-Jun kinases Nature 369 1994 156 160
4. E. Cano, and L.C. Mahadevan Parallel signal processing among mammalian MAPKs Trends Biochem. Sci. 20 1995 117 122
5. R. Seger, and E.G. Krebs The MAPK signaling cascade FASEB J. 9 1995 726 735
6. S. Tamura, M. Hanada, M. Ohnishi, K. Katsura, M. Sasaki, and T. Kobayashi Regulation of stress-activated protein kinase signaling pathways by protein phosphatases Eur. J. Biochem. 269 2002 1060 1066
7. J.A. McLachlan, C.D. Serkin, and O. Bakouche Dehydroepiandrosterone modulation of lipopolysaccharide-stimulated monocyte cytotoxicity J. Immunol. 156 1996 328 335
8. T. Yoshimata, A. Yoneyama, Y. Jin-no, N. Tamai, and Y. Kamiya Effects of dehydroepiandrosterone on mitogen-activated protein kinase in human aortic smooth muscle cells Life Sci. 65 1999 431 440
9. M.R. Williams, S. Ling, T. Dawood, K. Hashimura, A. Dai, H. Li, J.P. Liu, J.W. Funder, K. Sudhir, and P.A. Komesaroff Dehydroepiandrosterone inhibits human vascular smooth muscle cell proliferation independent of ARs and ERs J. Clin. Endocrinol. Metab. 87 2002 176 181
10. A.J. Morales, J.J. Nolan, J.C. Nelson, and S.S. Yen Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age J. Clin. Endocrinol. Metab. 78 1994 1360 1367
11. F. Labrie, P. Diamond, L. Cusan, J.L. Gomez, A. Belanger, and B. Candas Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women J. Clin. Endocrinol. Metab. 82 1997 3498 3505
12. W. Arlt, F. Callies, J.C. van Vlijmen, I. Koehler, M. Reincke, M. Bidlingmaier, D. Huebler, M. Oettel, M. Ernst, H.M. Schulte, and B. Allolio Dehydroepiandrosterone replacement in women with adrenal insufficiency N. Engl. J. Med. 341 1999 1013 1020
13. E.E. Baulieu, G. Thomas, S. Legrain, N. Lahlou, M. Roger, B. Debuire, V. Faucounau, L. Girard, M.P. Hervy, F. Latour, M.C. Leaud, A. Mokrane, H. Pitti-Ferrandi, C. Trivalle, O. de Lacharriere, S. Nouveau, B. Rakoto-Arison, J.C. Souberbielle, J. Raison, Y. Le Bouc, A. Raynaud, X. Girerd, and F. Forette Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue Proc. Natl. Acad. Sci. U. S. A. 97 2000 4279 4284
14. H. Nawata, T. Yanase, K. Goto, T. Okabe, and K. Ashida Mechanism of action of anti-aging DHEA-S and the replacement of DHEA-S Mech. Ageing Dev. 123 2002 1101 1106
15. Z. Ravid, N. Goldblum, R. Zaizov, M. Schlesinger, T. Kertes, J. Minowada, W. Verbi, and M. Greaves Establishment and characterization of a new leukaemic T-cell line (Peer) with an unusual phenotype Int. J. Cancer 25 1980 705 710
16. T. Okabe, M. Haji, R. Takayanagi, M. Adachi, K. Imasaki, F. Kurimoto, T. Watanabe, and H. Nawata Up-regulation of high-affinity dehydroepiandrosterone binding activity by dehydroepiandrosterone in activated human T lymphocytes J. Clin. Endocrinol. Metab. 80 1995 2993 2996
17. J.N. Siegel, R.D. Klausner, U.R. Rapp, and L.E. Samelson T cell antigen receptor engagement stimulates c-raf phosphorylation and induces c-raf-associated kinase activity via a protein kinase C-dependent pathway J. Biol. Chem. 265 1990 18472 18480
18. M. Izquierdo, S. Bowden, and D. Cantrell The role of Raf-1 in the regulation of extracellular signal-regulated kinase 2 by the T cell antigen receptor J. Exp. Med. 180 1994 401 406
19. M. Adachi, M. Sekiya, M. Isobe, Y. Kumura, Z. Ogita, Y. Hinoda, K. Imai, and A. Yachi Molecular cloning and chromosomal mapping of a human protein-tyrosine phosphatase LC-PTP Biochem. Biophys. Res. Commun. 186 1992 1607 1615
20. B. Zanke, H. Suzuki, K. Kishihara, L. Mizzen, M. Minden, A. Pawson, and T.W. Mak Cloning and expression of an inducible lymphoid-specific, protein tyrosine phosphatase (HePTPase) Eur. J. Immunol. 22 1992 235 239
21. M. Saxena, S. Williams, K. Tasken, and T. Mustelin Crosstalk between cAMP-dependent kinase and MAP kinase through a protein tyrosine phosphatase Nat. Cell Biol. 1 1999 305 311
22. M. Adachi, T. Miyachi, M. Sekiya, Y. Hinoda, A. Yachi, and K. Imai Structure of the human LC-PTP (HePTP) gene: similarity in genomic organization within protein-tyrosine phosphatase genes Oncogene 9 1994 3031 3035
23. F. Labrie, A. Belanger, J. Simard, L.-T. Van, and C. Labrie DHEA and peripheral androgen and estrogen formation: intracinology Ann. N.Y. Acad. Sci. 774 1995 16 28
24. R.H. Derksen Dehydroepiandrosterone (DHEA) and systemic lupus erythematosus Semin. Arthritis Rheum. 27 1998 335 347
25. D.M. Chang, J.L. Lan, H.Y. Lin, and S.F. Luo Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: a multicenter randomized, double-blind, placebo-controlled trial Arthritis Rheum. 46 2002 2924 2927
26. M.A. Petri, R.G. Lahita, R.F. Van Vollenhoven, J.T. Merrill, M. Schiff, E.M. Ginzler, V. Strand, A. Kunz, K.J. Gorelick, and K.E. Schwartz Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial Arthritis Rheum. 46 2002 1820 1829
27. R.F. van Vollenhoven Dehydroepiandrosterone in systemic lupus erythematosus Rheum. Dis. Clin. North Am. 26 2000 349 362
28. A.C. Grammer, R. Fischer, O. Lee, X. Zhang, and P.E. Lipsky Flow cytometric assessment of the signaling status of human B lymphocytes from normal and autoimmune individuals Arthritis Res. Ther. 6 2004 28 38 (Electronic publication 2004 Feb 2005)
29. R.L. Thurmond, S.A. Wadsworth, P.H. Schafer, R.A. Zivin, and J.J. Siekierka Kinetics of small molecule inhibitor binding to p38 kinase Eur. J. Biochem. 268 2001 5747 5754
30. H. Shimizu, M. Shiota, N. Yamada, K. Miyazaki, N. Ishida, S. Kim, and H. Miyazaki Low M(r) protein tyrosine phosphatase inhibits growth and migration of vascular smooth muscle cells induced by platelet-derived growth factor Biochem. Biophys. Res. Commun. 289 2001 602 607
31. M.E. Poynter, and R.A. Daynes Peroxisome proliferator-activated receptor alpha activation modulates cellular redox status, represses nuclear factor-kappaB signaling, and reduces inflammatory cytokine production in aging J. Biol. Chem. 273 1998 32833 32841
32. R. Dashtaki, A.R. Whorton, T.M. Murphy, P. Chitano, W. Reed, and T.P. Kennedy Dehydroepiandrosterone and analogs inhibit DNA binding of AP-1 and airway smooth muscle proliferation J. Pharmacol. Exp. Ther. 285 1998 876 883
33. D. Liu, and J.S. Dillon Dehydroepiandrosterone activates endothelial cell nitric-oxide synthase by a specific plasma membrane receptor coupled to Galpha(i2,3) J. Biol. Chem. 277 2002 21379 21388 (Electronic publication 22002 Apr 21304)
34. M. Saxena, S. Williams, J. Brockdorff, J. Gilman, and T. Mustelin Inhibition of T cell signaling by mitogen-activated protein kinase-targeted hematopoietic tyrosine phosphatase (HePTP) J. Biol. Chem. 274 1999 11693 11700
35. M. Oh-hora, M. Ogata, Y. Mori, M. Adachi, K. Imai, A. Kosugi, and T. Hamaoka Direct suppression of TCR-mediated activation of extracellular signal-regulated kinase by leukocyte protein tyrosine phosphatase, a tyrosine-specific phosphatase J. Immunol. 163 1999 1282 1288
36. S.M. Pettiford, and R. Herbst The MAP-kinase ERK2 is a specific substrate of the protein tyrosine phosphatase HePTP Oncogene 19 2000 858 869
37. M. Camps, A. Nichols, and S. Arkinstall Dual specificity phosphatases: a gene family for control of MAP kinase function FASEB J. 14 2000 6 16
38. A. Gjorloff-Wingren, M. Saxena, S. Han, X. Wang, A. Alonso, M. Renedo, P. Oh, S. Williams, J. Schnitzer, and T. Mustelin Subcellular localization of intracellular protein tyrosine phosphatases in T cells Eur. J. Immunol. 30 2000 2412 2421
39. M. Saxena, S. Williams, J. Gilman, and T. Mustelin Negative regulation of T cell antigen receptor signal transduction by hematopoietic tyrosine phosphatase (HePTP) J. Biol. Chem. 273 1998 15340 15344
40. M. Fiscella, H. Zhang, S. Fan, K. Sakaguchi, S. Shen, W.E. Mercer, G.F. Vande Woude, P.M. O'Connor, and E. Appella Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner Proc. Natl. Acad. Sci. U. S. A. 94 1997 6048 6053
41. M. Takekawa, M. Adachi, A. Nakahata, I. Nakayama, F. Itoh, H. Tsukuda, Y. Taya, and K. Imai p53-inducible wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation EMBO J. 19 2000 6517 6526